Changes in serum adhesion molecules, chemokines, cytokines, and tissue remodeling factors in euthyroid women without thyroid antibodies who are at risk for autoimmune thyroid disease: A hypothesis on the early phases of the endocrine autoimmune reaction

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 6, 2013, Pages 2460-2468

  Beumer, Wouter ^a   Effraimidis, Grigoris ^b   Drexhage, Roosmarijn C ^a   Wiersinga, Wilmar M ^b   Drexhage, Hemmo A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; CELL ADHESION MOLECULE; CHEMOKINE; COLLAGENASE 3; CYTOKINE; FIBRONECTIN; GROWTH DIFFERENTIATION FACTOR 15; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 4; PLATELET DERIVED GROWTH FACTOR BB; THROMBOSPONDIN 1; THYROID PEROXIDASE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN A;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EUTHYROIDISM; FAMILY HISTORY; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SEROCONVERSION; UPREGULATION;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CELL ADHESION MOLECULES; CHEMOKINES; CYTOKINES; FEMALE; HUMANS; IODIDE PEROXIDASE; MIDDLE AGED; RISK; THYROID DISEASES; THYROID GLAND;

ANIMALIA;

EID: 84878519889     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4122     Document Type: Article

References (43)

1. Eschler DC, Hasham A, Tomer Y. Cutting edge: the etiology of autoimmune thyroid diseases. Clin Rev Allergy Immunol. 2011;41:190-197.
2. Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab. 2001;86:930-934. (Pubitemid 32207518)
3. Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab. 2000;85:536-539. (Pubitemid 32273630)
4. Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol. 2004;150:605-618. (Pubitemid 38786529)
5. Strieder TG, Tijssen JG, Wenzel BE, Endert E, Wiersinga WM. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score. Arch Intern Med. 2008;168:1657-1663.
6. Bilimoria KY, Pescovitz OH, DiMeglio LA. Autoimmune thyroid dysfunction in children with type 1 diabetes mellitus: screening guidelines based on a retrospective analysis. J Pediatr Endocrinol Metab JPEM. 2003;16:1111-1117. (Pubitemid 37336857)
7. Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev. 2001;22:605-630. (Pubitemid 32955246)
8. Brand OJ, Gough SC. Immunogenetic mechanisms leading to thyroid autoimmunity: recent advances in identifying susceptibility genes and regions. Curr Genomics. 2011;12:526-541.
9. Voorby HA, Kabel PJ, de Haan M, et al. Dendritic cells and class II MHC expression on thyrocytes during the autoimmune thyroid disease of the BB rat. Clin Immunol Immunopathol. 1990;55:9-22. (Pubitemid 20116697)
10. Many MC, Maniratunga S, Varis I, Dardenne M, Drexhage HA, Denef JF. Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosis. J Endocrinol. 1995;147:311-320.
11. Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF, Weetman AP. Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf). 2003;59:207-213. (Pubitemid 36918657)
12. Martin J, Collot-Teixeira S, McGregor L, McGregor JL. The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes. Curr Pharmaceut Design. 2007;13:1751-1759. (Pubitemid 46979713)
13. Kirsch T, Woywodt A, Klose J, et al. Endothelial-derived thrombospondin-1 promotes macrophage recruitment and apoptotic cell clearance. J Cell Mol Med. 2010;14:1922-1934.
14. van der Heul-Nieuwenhuijsen L, Padmos RC, Drexhage RC, de Wit H, Berghout A, Drexhage HA. An inflammatory gene-expression fingerprint in monocytes of autoimmune thyroid disease patients. J Clin Endocrinol Metab. 2010;95:1962-1971.
15. Witkowska AM, Borawska MH. Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Eur Cytokine Netw. 2004;15:91-98. (Pubitemid 38980081)
16. De Bellis A, Di Martino S, Fiordelisi F, et al. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy. J Clin Endocrinol Metab. 1998;83:1222-1225. (Pubitemid 28496397)
17. Figueroa-Vega N, Alfonso-Perez M, Cuesta-Mateos C, et al. Tie-2 is overexpressed by monocytes in autoimmune thyroid disorders and participates in their recruitment to the thyroid gland. J Clin Endocrinol Metab. 2009;94:2626-2633.
18. Kohno Y, Tanimoto A, Cirathaworn C, Shimajiri S, Tawara A, Sasaguri Y. GM-CSF activates RhoA, integrin and MMP expression in human monocytic cells. Pathol Int. 2004;54:693-702. (Pubitemid 39297295)
19. Effraimidis G, Tijssen JG, Wiersinga WM. Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study. J Clin Endocrinol Metab. 2009;94:1324-1328.
20. Strieder TG, Prummel MF, Tijssen JG, Endert E, Wiersinga WM. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf). 2003;59:396-401. (Pubitemid 37046995)
21. Goldstein S, Moerman EJ, Soeldner JS, Gleason RE, Barnett DM. Diabetes mellitus and genetic prediabetes. Decreased replicative capacity of cultured skin fibroblasts. J Clin Invest. 1979;63:358-370. (Pubitemid 9130198)
22. Lam-Tse WK, Batstra MR, Koeleman BP, et al. The association between autoimmune thyroiditis, autoimmune gastritis and type 1 diabetes. Pediatr Endocrinol Rev PER. 2003;1:22-37.
23. Simons PJ, Delemarre FG, Jeucken PH, Drexhage HA. Pre-autoimmune thyroid abnormalities in the biobreeding diabetes-prone (BBDP) rat: a possible relation with the intrathyroid accumulation of dendritic cells and the initiation of the thyroid autoimmune response. J Endocrinol. 1998;157:43-51. (Pubitemid 28177491)
24. Truden JL, Sundick RS, Levine S, Rose NR. The decreased growth rate of obese strain chicken thyroid cells provides in vitro evidence for a primary target organ abnormality in chickens susceptible to autoimmune thyroiditis. Clin Immunol Immunopathol. 1983;29:294-305. (Pubitemid 13018224)
25. Many MC, Drexhage HA, Denef JF. High frequency of thymic ectopy in thyroids from autoimmune prone nonobese diabetic female mice. Lab Invest. 1993;69:364-367. (Pubitemid 23315723)
26. Rosmalen JG, Leenen PJ, Pelegri C, Drexhage HA, Homo-Delarche F. Islet abnormalities in the pathogenesis of autoimmune diabetes. Trends Endocrinol Metab TEM. 2002;13:209-214. (Pubitemid 36733981)
27. Geutskens SB, Homo-Delarche F, Pleau JM, Durant S, Drexhage HA, Savino W. Extracellular matrix distribution and islet morphology in the early postnatal pancreas: anomalies in the non-obese diabetic mouse. Cell Tiss Res. 2004;318:579-589. (Pubitemid 40109947)
28. Hanifi-Moghaddam P, Kappler S, Seissler J, et al. Altered chemokine levels in individuals at risk of type 1 diabetes mellitus. Diabet Med. 2006;23:156-163.
29. Jungheim K, Caspar G, Usadel KH, Schumm-Draeger PM. Lymphocyte homing in xenotransplanted human thyroid tissue can be inhibited by LFA-1 and ICAM-1 antibodies. Thyroid. 2004;14:3-11. (Pubitemid 38282931)
30. Marazuela M. Lymphocyte traffic and homing in autoimmune thyroid disorders. Eur J Endocrinol. 1999;140:287-290. (Pubitemid 29217098)
31. Bouma G, Coppens JM, Mourits S, et al. Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice. Eur J Immunol. 2005;35:2386-2396. (Pubitemid 41179759)
32. Bouma G, Nikolic T, Coppens JM, et al. NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation. Eur J Immunol. 2005;35:225-235. (Pubitemid 40123869)
33. Poligone B, Weaver DJ Jr, Sen P, Baldwin AS Jr, Tisch R. Elevated NF-κB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J Immunol. 2002;168:188-196. (Pubitemid 34014118)
34. Marleau AM, Singh B. Myeloid dendritic cells in non-obese diabetic mice have elevated costimulatory and T helper-1-inducing abilities. J Autoimmun. 2002;19:23-35. (Pubitemid 35205197)
35. Sen P, Bhattacharyya S, Wallet M, et al. NF-κB hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages. J Immunol. 2003;170:1770-1780. (Pubitemid 36197392)
36. Stoffels K, Overbergh L, Giulietti A, et al. NOD macrophages produce high levels of inflammatory cytokines upon encounter of apoptotic or necrotic cells. J Autoimmun. 2004;23:9-15. (Pubitemid 38953788)
37. Rothe H, Ongoren C, Martin S, Rosen P, Kolb H. Abnormal TNF-α production in diabetes-prone BB rats: enhanced TNF-α expression and defective PGE2 feedback inhibition. Immunology. 1994;81:407-413.
38. Wildenberg ME, van Helden-Meeuwsen CG, van de Merwe JP, Moreno C, Drexhage HA, Versnel MA. Lack of CCR5 on dendritic cells promotes a proinflammatory environment in submandibular glands of the NOD mouse. J Leukocyte Biol. 2008;83:1194-1200. (Pubitemid 351960351)
39. Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med. 2004;199:1467-1477. (Pubitemid 38780402)
40. Cheatem D, Ganesh BB, Gangi E, Vasu C, Prabhakar BS. Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function. Clin Immunol. 2009;131:260-270.
41. Delemarre FG, Simons PJ, de Heer HJ, Drexhage HA. Signs of immaturity of splenic dendritic cells from the autoimmune prone biobreeding rat: consequences for the in vitro expansion of regulator and effector T cells. J Immunol. 1999;162:1795-1801. (Pubitemid 29307060)
42. Radosevic K, Casteels KM, Mathieu C, Van Ewijk W, Drexhage HA, Leenen PJ. Splenic dendritic cells from the non-obese diabetic mouse induce a prolonged proliferation of syngeneic T cells. A role for an impaired apoptosis of NOD T cells? J Autoimmun. 1999;13:373-382. (Pubitemid 30014525)
43. Gaglia JL, Guimaraes AR, Harisinghani M, et al. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest. 2011;121:442-445.